Celerion Snapshot
Celerion’s focus is on the implementation of innovative strategies to generate key data very early to enable go/no-go decisions in drug development. With a large clinical capacity of more than 600 beds , efficient bioanalytical laboratories and experienced scientific staff, Celerion offers one of the most experienced clinical pharmacology research networks in the industry.
Our 40+ years of experience, innovative strategies, global capabilities, and expertise in early phase research make us faster than our competitors. That means you get key data sooner, enabling you to make earlier go/no-go decisions about your drug's development. It’s all in the name: Celerion is derived from the Latin celeritas (meaning swiftness and speed), which reflects our founding principle—that fast, reliable research is vital to a product's success. Our vision is to be the premier provider of early stage drug development solutions to you, achieved through experienced leadership, the passion of our employees and a commitment to excellence.
Our mission is to focus every day on helping our clients get their drugs to market, so that they touch the lives of our family, friends and people in need around the world.
We have become aware of an individual who is falsely representing themselves as a member of the Celerion HR team. Please be cautious when responding to any communication that purports to come from Celerion. All email communication from Celerion will come from an email address appended @celerion.com. No other addresses are legitimate.
Our mission is to focus every day on helping our clients get their drugs to market, so that they touch the lives of our family, friends and people in need around the world.
We have become aware of an individual who is falsely representing themselves as a member of the Celerion HR team. Please be cautious when responding to any communication that purports to come from Celerion. All email communication from Celerion will come from an email address appended @celerion.com. No other addresses are legitimate.
